Many cancer cells rely heavily on glucose (the Warburg effect) and cannot efficiently use ketones. A strict ketogenic diet may starve these tumors while nourishing healthy cells. In one case, it led to a 70% reduction in cancer markers in six weeks, far exceeding chemotherapy's expected 30%.

Previous neutropenic diet studies were flawed by using fever as an endpoint. Since only about 25% of fevers represent a true, documented infection, this trial's use of a robust "major infection" endpoint provided a much clearer and more accurate signal of dietary risk, revealing differences other studies missed.

A patient's reminder that even clinically-graded "mild" side effects like grade 2 diarrhea can be debilitating highlights a disconnect between clinical assessment and patient experience. This underscores the need for oncologists to consider the real-world impact of toxicities, like the ability to leave the house, when choosing a treatment regimen.

Generic advice like "diet and exercise" is ineffective for cancer patients. Clinicians should adopt a pharmaceutical model, prescribing specific types and "doses" of diet and exercise based on a patient's unique metabolic profile, treatment, and clinical goals, rather than handing out a generic brochure.

Increasing fiber intake may not improve gut health if an individual's microbiome is already depleted. Research suggests many people in the industrialized world have lost the specific microbes needed to break down diverse fibers. Without these microbes, the fiber passes through without providing benefits, highlighting the need to first restore microbial diversity.

In a multivariable analysis, the single most important risk factor for infection was the duration of neutropenia. The infection rates between the liberalized and neutropenic diet groups only began to diverge after two weeks, suggesting the diet's risk is most pronounced in patients with prolonged immunosuppression.

For patients with pre-cancerous conditions like MGUS and smoldering myeloma, diet can significantly influence their progression to an active myeloma diagnosis. This positions dietary intervention not just as supportive care but as a key tool for mitigating disease progression.

While GLP-1 drugs can jumpstart weight loss by reducing appetite, they don't address poor food quality. If users simply eat less ultra-processed food, they risk severe protein and micronutrient deficiencies, leading to different long-term health consequences.

The increased infection rate in patients on a liberalized diet was specifically driven by a twofold increase in organisms originating from the GI tract. This provides a strong mechanistic link, suggesting the diet introduces pathogens that translocate through the gut barrier compromised by chemotherapy or transplant.